Article
The BRAF mutation is associated with the prognosis in colorectal cancer.
Journal of cancer research and clinical oncology - 1 Nov 2014
Ahn Tae Sung, Jeong Dongjun, Son Myoung Won, Jung Haeil, Park Soyoung, Kim Hyungjoo, Bae Sang Byung, Kim Han Jo, Jeon Young-Woo, Lee Moon Soo, Baek Moo-Jun
Abstract excerpt
BACKGROUND: Two members of the Ras/Raf signaling pathway, KRAS and B-raf, are suspected to be involved in the stepwise progression of colorectal cancer (CRC) tumorigenesis. OBJECTIVE: We compared the KRAS and BRAF mutation status of CRC patients with their clinicopathological characteristics and examined the effect of mutation status on survival rates. METHODS: DNA was extracted from 164 samples, and the mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
